Frank Zurfley, MD
MOHS-Micrographic Surgery · Bluffton, SCNPI 1235660952
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Regeneron Healthcare Solutions, Inc. accounts for 61.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for mohs-micrographic surgery clinicians in SC, where the typical reported total is $2,794.
Across 2 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$31
- AbbVie$19
Across 35 payments — averaging $2405.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$84K
What the payments were for
- Food & beverage$49100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| AbbVie | 1 | $19 |
How this compares
$49 in reported general payments places this provider in the 10th percentile of 22 mohs-micrographic surgery providers in South Carolina.
See all mohs-micrographic surgery providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 44 | $2,221 |
| Clobetasol Propionate | 44 | $1,857 |
| Ketoconazole | 44 | $606 |
| Doxycycline Hyclate | 18 | $522 |
| Betamethasone Dipropionate | 15 | $477 |
| Triamcinolone Acetonide | 52 | $428 |
| Doxycycline Monohydrate | 12 | $423 |
| Cephalexin | 150 | $318 |
| Gentamicin Sulfate | 13 | $280 |
| Mupirocin | 35 | $256 |
| Fluconazole | 16 | $139 |
| Hydrocortisone | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Bluffton
- Joseph McGowanBluffton$10K
- Michael SarradetBluffton$205
- Fabrizio GalimbertiConway$765K
- Yumeng LiConway$33K
- Brandon CoakleyMyrtle Beach$24K
- Bradley SaylorsNorth Charleston$8K
- Ruth McTigheMt Pleasant$7K
- Taylor MulkeyMt Pleasant$7K
- Julie JeffersonGreenville$5K
- Richard LucarielloMyrtle Beach$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.